Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

Recruiting N/A Interventional Study
Blood Cancer Leukemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
40 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process, called DIVERSE.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
CAB Participant Inclusion Criteria: * Age 18 or older * English speaking * Ability to understand and willingness to provide oral consent * DFCI patient who are in remission from a blood cancer \>1 year will be preferred. CAB Participant Exclusion Criteria: * Adults unable to consent * Individuals…
Contacts

Andrew Hantel, MD

617-582-9394

Andrew_Hantel@dfci.harvard.edu

CONTACT

Oldy S Bejarano, MPH

857-215-2365

oldy_bejarano@dfci.harvard.edu

CONTACT